Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
Goethe University Frankfurt · Deutsches Herzzentrum der Charité · +11 more institutions
Indexed incrossrefpubmed
Abstract
Background
Pilot trials suggest that the intracoronary administration of autologous progenitor cells may improve left ventricular function after acute myocardial infarction.
Methods
In a multicenter trial, we randomly assigned 204 patients with acute myocardial infarction to receive an intracoronary infusion of progenitor cells derived from bone marrow (BMC) or placebo medium into the infarct artery 3 to 7 days after successful reperfusion therapy.
Citation impact
1,886
total citations
- FWCI
- 107.37
- Percentile
- 100%
- References
- 22
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Medicine
- Myocardial infarction
- Ejection fraction
- Cardiology
- Internal medicine
- Progenitor cell
- Infarction
- Revascularization
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.